DOI: 10.1055/s-00000005

Aktuelle Rheumatologie

References

Braun J, Baraliakos X, Deodhar A. et al.
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.

Rheumatology (Oxford) 2018;
DOI: 10.1093/rheumatology/key375.

Braun J, Baraliakos X, Deodhar A. et al.
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.

Rheumatology (Oxford) 2018;
DOI: 10.1093/rheumatology/key375.

Download Bibliographical Data

Search in: